Predictors of life-threatening events in adult patients with left ventricular noncompaction

Table 5 Factors associated with thrombotic and/or embolic events in patients with left ventricular noncompaction, mean ± SD/median (minimum-maximum)

Parameter	Thrombosis and/or embolism		P value
	Present	Absent
n	28	97
NYHA CHF class	3 (2.0-3.0)	2 (1.0-3.0)	0.006
LVEF, %	31.3 ± 11.7	40.8 ± 13.9	0.001
LVEDD, cm	6.5 ± 0.9	5.9 ± 0.8	0.006
LVEDV, mL	184.2 ± 60.8	149.6 ± 66.5	0.005
LVESV, mL	126.7 ± 62.9	94.1 ± 53.4	0.010
LA volume, mL	109.3 ± 31.8	93.2 ± 39.2	0.014
RVEDD, cm	3.4 ± 0.8	2.9 ± 0.6	0.002
Е/А ratio	2.1 ± 0.8	1.5 ± 0.9	0.010
LVOT VTI	10.0 ± 3.5	12.7 ± 3.5	0.016
Atrial fibrillation, %	39.3	27.8	0.210
Duration of disease, months	22.5 (4.8-51.0)	53.0 (13.0-120.0)	0.020

NYHA: New York Heart Association; CHF: Chronic heart failure; LVEF: Left ventricular ejection fraction; LVEDD: Left ventricular end diastolic diameter; LVEDV: Left ventricular end diastolic volume; LVESV: Left ventricular end systolic volume; LA: Left atrium; RVEDD: Right ventricular end-diastolic diameter; LVOT VTI: Left ventricular outflow tract velocity-time integral.